Eastwood Bio-Medical Canada Inc (V:EBM) — Market Cap & Net Worth
Market Cap & Net Worth: Eastwood Bio-Medical Canada Inc (EBM)
Eastwood Bio-Medical Canada Inc (V:EBM) has a market capitalization of $44.78 Million (CA$61.90 Million) as of June 17, 2026. Listed on the V stock exchange, this Canada-based company holds position #22397 globally and #803 in its home market, demonstrating a 14.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eastwood Bio-Medical Canada Inc's stock price CA$0.93 by its total outstanding shares 68885969 (68.89 Million). Review EBM current and long-term liabilities to assess the company's total debt and financial obligations.
Eastwood Bio-Medical Canada Inc Market Cap History: 2015 to 2026
Eastwood Bio-Medical Canada Inc's market capitalization history from 2015 to 2026. Data shows growth from $17.44 Million to $45.84 Million (3.41% CAGR).
Eastwood Bio-Medical Canada Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eastwood Bio-Medical Canada Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
51.61x
Eastwood Bio-Medical Canada Inc's market cap is 51.61 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.23 Million | $463.93K | -$468.48K | 13.43x | N/A |
| 2017 | $3.74 Million | $479.73K | -$489.62K | 7.79x | N/A |
| 2018 | $274.07 Million | $743.97K | -$861.98K | 368.39x | N/A |
| 2019 | $124.08 Million | $1.29 Million | -$579.68K | 95.97x | N/A |
| 2020 | $99.66 Million | $718.34K | -$860.03K | 138.74x | N/A |
| 2021 | $69.76 Million | $981.05K | -$611.34K | 71.11x | N/A |
| 2022 | $49.83 Million | $1.30 Million | -$160.58K | 38.34x | N/A |
| 2023 | $27.41 Million | $867.94K | -$546.60K | 31.58x | N/A |
| 2024 | $26.91 Million | $702.08K | -$455.87K | 38.33x | N/A |
| 2025 | $40.36 Million | $782.08K | -$332.77K | 51.61x | N/A |
Competitor Companies of EBM by Market Capitalization
Companies near Eastwood Bio-Medical Canada Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Eastwood Bio-Medical Canada Inc by market ranking:
- Sysco Corporation (NYSE:SYY): Ranked #718 globally with a market cap of $38.17 Billion USD.
- US Foods Holding Corp (NYSE:USFD): Ranked #1280 globally with a market cap of $20.40 Billion USD.
- Performance Food Group Co (NYSE:PFGC): Ranked #1662 globally with a market cap of $14.78 Billion USD.
- JERONIMO MARTINS UN.ADR/2 (F:JEM0): Ranked #1789 globally with a market cap of $13.46 Billion USD ( €11.51 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #718 | Sysco Corporation | NYSE:SYY | $38.17 Billion | $79.69 |
| #1280 | US Foods Holding Corp | NYSE:USFD | $20.40 Billion | $93.44 |
| #1662 | Performance Food Group Co | NYSE:PFGC | $14.78 Billion | $104.10 |
| #1789 | JERONIMO MARTINS UN.ADR/2 | F:JEM0 | $13.46 Billion | €40.60 |
Eastwood Bio-Medical Canada Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Eastwood Bio-Medical Canada Inc's market cap moved from $17.44 Million to $ 45.84 Million, with a yearly change of 3.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$45.84 Million | +13.58% |
| 2025 | CA$40.36 Million | +50.00% |
| 2024 | CA$26.91 Million | -1.82% |
| 2023 | CA$27.41 Million | -45.00% |
| 2022 | CA$49.83 Million | -28.57% |
| 2021 | CA$69.76 Million | -30.00% |
| 2020 | CA$99.66 Million | -19.68% |
| 2019 | CA$124.08 Million | -54.73% |
| 2018 | CA$274.07 Million | +7233.33% |
| 2017 | CA$3.74 Million | -40.00% |
| 2016 | CA$6.23 Million | -64.29% |
| 2015 | CA$17.44 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Eastwood Bio-Medical Canada Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $44.78 Million USD |
| MoneyControl | $44.78 Million USD |
| MarketWatch | $44.78 Million USD |
| marketcap.company | $44.78 Million USD |
| Reuters | $44.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appeti… Read more